AC
HALO icon

Allstate Corporation’s Halozyme HALO Stock Holding History

Allstate Corporation’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$724K Buy
+11,206
New +$790K 0.01% 912

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Allstate Corporation's HALO Position: Q1 2026 in Review

Allstate Corporation opened a new position in Halozyme (HALO) in Q1 2026: 11,206 shares worth $724K. The stake represents 0.01% of the portfolio and ranks #912 among its holdings.

635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Allstate Corporation held 11,206 shares of Halozyme worth $724K as of Q1 2026.
  • Halozyme was a new Allstate Corporation position in Q1 2026.
  • Halozyme made up 0.01% of Allstate Corporation's portfolio in Q1 2026, its #912 holding.
  • 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Allstate Corporation's 13F filing for Q1 2026, filed 11 May 2026.